Article
The Alzheimer's prevention initiative composite cognitive test score: sample size estimates for the evaluation of preclinical Alzheimer's disease treatments in presenilin 1 E280A mutation carriers.
The Journal of clinical psychiatry - 1 Jun 2014
Ayutyanont Napatkamon, Langbaum Jessica B S, Hendrix Suzanne B, Chen Kewei, Fleisher Adam S, Friesenhahn Michel, Ward Michael, Aguirre Camilo, Acosta-Baena Natalia, Madrigal Lucìa, Muñoz Claudia, Tirado Victoria, Moreno Sonia, Tariot Pierre N, Lopera Francisco, Reiman Eric M
Abstract excerpt
OBJECTIVE: To identify a cognitive composite that is sensitive to tracking preclinical Alzheimer's disease decline to be used as a primary end point in treatment trials. METHOD: We capitalized on longitudinal data collected from 1995 to 2010 from cognitively unimpaired presenilin 1 (PSEN1) E280A mutation carriers from the world's largest known early-onset autosomal dominant Alzheimer's disease kindred to identify...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
